Cervical cancer treatment and research at Dana-Farber
The development of the Pap test has dramatically improved cervical cancer outcomes because it is able to detect the disease in its pre-invasive or early invasive stages, when it is much easier to treat. According to the American Cancer Society, early stage, invasive cervical cancer is one of the most successfully treatable forms of cancer, with roughly 92 percent of patients surviving the disease at least five years. That being said, more than 10 percent of women in the U.S. do not receive regular cervical cancer screenings.
Related News
- HPV facts: Cervical cancer and the new vaccine
- Dana-Farber studies and treats cervical cancer while advocating Pap smears
- New technology in fight against reproductive system tumors
- Underserved U.S. minorities face "unequal burden of cancer" that must be corrected, according to reports
